Total IgG, IgA, and IgM levels were significantly lower in the CVID patients compared to the HCs after both stimulation protocols (Figure 4A–B), with the exception of IgM levels following condition I stimulation, which were similar between the two groups (Figure 4C). This evidence concerns the gene CD40LG and common variable immunodeficiency.